A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling
In this study, we examined the effect of the GP130-targeting molecule, LMT-28, on lipopolysaccharide- (LPS-) induced bone resorption around implants in diabetic models using in vitro and rat animal experiments. First, LMT-28 was added to osteoblasts stimulated by LPS and advanced glycation end produ...
Saved in:
Main Authors: | Qi-qi Liu, Wei-wei Wu, Jian Yang, Rui-bin Wang, Ling-ling Yuan, Pei-zhao Peng, Mao-yun Zeng, Ke Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/9330439 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple Myeloma and B Cell Lymphoma. Investigation of IL-6, IL-6 Receptor Antagonist (IL-6RA), and GP130 Antagonist (GP130A) Using Various Parameters in an In Vitro Model
by: Eva Kovacs
Published: (2006-01-01) -
Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
by: Mario Luca Morieri, et al.
Published: (2017-01-01) -
Role of soluble gp130 in the tumour necrosis factor-α expression and its production by peripheral blood mononuclear cells
by: E. Jablonskaca, et al.
Published: (2003-01-01) -
GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma
by: Shujie Wang, et al.
Published: (2025-02-01) -
Corrosion of a chimney liner operated for 130,000 hours
by: Gwoździk M.
Published: (2023-01-01)